Israel Englander Kronos Bio, Inc. Transaction History
Millennium Management LLC
- $199 Billion
- Q3 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 2,045,803 shares of KRON stock, worth $1.94 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,045,803
Previous 1,857,988
10.11%
Holding current value
$1.94 Million
Previous $2.3 Million
11.2%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding KRON
# of Institutions
56Shares Held
19.8MCall Options Held
9.3KPut Options Held
100-
Vida Ventures Advisors, LLC2.77MShares$2.63 Million3.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.83 Million0.0% of portfolio
-
Partners Capital Investment Group, LLP Boston, MA1.61MShares$1.53 Million0.03% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$1.37 Million0.1% of portfolio
-
Acadian Asset Management LLC Boston, MA1.3MShares$1.24 Million0.0% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $53.9M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...